Pages that link to "Q34717857"

The following pages link to Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein (Q34717857):

Displaying 27 items.

• Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR (Q33966987) (← links)
• Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication (Q34261905) (← links)
• Infection and cervical neoplasia: facts and fiction. (Q34843163) (← links)
• The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway (Q37003173) (← links)
• Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions. (Q37009828) (← links)
• PI3K signaling regulates rapamycin-insensitive translation initiation complex formation in vaccinia virus-infected cells (Q37145278) (← links)
• mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix (Q37406873) (← links)
• Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis (Q37485899) (← links)
• Emerging biological treatments for uterine cervical carcinoma. (Q37540968) (← links)
• Virus versus host cell translation love and hate stories (Q37583114) (← links)
• Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16. (Q37590569) (← links)
• A Review of mTOR Pathway Inhibitors in Gynecologic Cancer (Q37668889) (← links)
• Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development (Q37699247) (← links)
• Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms (Q38061056) (← links)
• Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma. (Q38408862) (← links)
• A Review of Functional Motifs Utilized by Viruses. (Q39156048) (← links)
• Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif (Q39354536) (← links)
• Interkeratin Peptide-Protein Interactions That Promote HPV16 E7 Gene Expression (Q39644878) (← links)
• The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis (Q39680127) (← links)
• Activities of E7 promoters in the human papillomavirus type 16 genome during cell differentiation (Q39735079) (← links)
• A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I. (Q39748979) (← links)
• Rational Design for Cervical Cancer Therapeutics: Cellular and Non-Cellular Based Strategies on the Horizon for Recurrent, Metastatic or Refractory Cervical Cancer. (Q49797507) (← links)
• Human papillomavirus 16 E7 oncoprotein alters the expression profiles of circular RNAs in Caski cells (Q58549502) (← links)
• mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer (Q92541799) (← links)
• Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review) (Q92814806) (← links)
• Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence (Q98164379) (← links)
• Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway (Q101566535) (← links)